Tag Archives: PODD

Hot Medical Stocks To Watch Right Now

First American Trust FSB acquired a new stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 17,498 shares of the medical research company’s stock, valued at approximately $3,624,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Johnson Financial Group Inc. boosted its holdings in Thermo Fisher Scientific by 2,608.7% during the first quarter. Johnson Financial Group Inc. now owns 623 shares of the medical research company’s stock worth $129,000 after purchasing an additional 600 shares during the last quarter. Virtue Capital Management LLC purchased a new position in Thermo Fisher Scientific during the fourth quarter worth about $127,000. Premia Global Advisors LLC purchased a new position in Thermo Fisher Scientific during the fourth quarter worth about $131,000. Private Capital Group LLC boosted its holdings in Thermo Fisher Scientific by 57.3% during the first quarter. Private Capital Group LLC now owns 865 shares of the medical research company’s stock worth $179,000 after purchasing an additional 315 shares during the last quarter. Finally, Jacobi Capital Management LLC boosted its holdings in Thermo Fisher Scientific by 45.5% during the first quarter. Jacobi Capital Management LLC now owns 908 shares of the medical research company’s stock worth $184,000 after purchasing an additional 284 shares during the last quarter. Hedge funds and other institutional investors own 85.76% of the company’s stock.

Hot Medical Stocks To Watch Right Now: Jinpan International Limited(JST)

Advisors’ Opinion:

  • [By Logan Wallace]

    A number of firms have modified their ratings and price targets on shares of JOST Werke (ETR: JST) recently:

    5/25/2018 – JOST Werke was given a new €46.00 ($53.49) price target on by analysts at Deutsche Bank AG. They now have a “buy” rating on the stock. 5/25/2018 – JOST Werke was given a new €46.00 ($53.49) price target on by analysts at Deutsche Bank AG. They now have a “buy” rating on the stock. 5/25/2018 – JOST Werke was given a new €47.00 ($54.65) price target on by analysts at Warburg Research. They now have a “buy” rating on the stock. 5/24/2018 – JOST Werke was given a new €45.00 ($52.33) price target on by analysts at JPMorgan Chase & Co.. They now have a “neutral” rating on the stock. 5/8/2018 – JOST Werke was given a new €46.00 ($53.49) price target on by analysts at Deutsche Bank AG. They now have a “buy” rating on the stock. 4/4/2018 – JOST Werke was given a new €47.00 ($54.65) price target on by analysts at Warburg Research. They now have a “buy” rating on the stock.

    Shares of JOST Werke traded down €0.15 ($0.17), hitting €38.10 ($44.30), during mid-day trading on Friday, according to MarketBeat. 8,510 shares of the company’s stock were exchanged, compared to its average volume of 35,469. JOST Werke AG has a 52 week low of €27.20 ($31.63) and a 52 week high of €47.50 ($55.23).

  • [By Joseph Griffin]

    Warburg Research set a €47.00 ($55.95) price target on JOST Werke (ETR:JST) in a report published on Friday. The firm currently has a buy rating on the stock.

  • [By Joseph Griffin]

    Deutsche Bank set a €46.00 ($53.49) price target on JOST Werke (ETR:JST) in a research report sent to investors on Friday. The firm currently has a buy rating on the stock.

Hot Medical Stocks To Watch Right Now: (LVMUY)

Advisors’ Opinion:

  • [By ]

    Two years ago, I discussed LVMH (OTCPK:LVMUY) (OTCPK:LVMHF) in another article here on Seeking Alpha. Although I wasnt too impressed with the companys free cash flow yield, I did agree this company deserved a premium valuation. And on top of that, I was expecting its strong growth results to continue in the years ahead. Were now two years later, and LVMH has delivered on every front. Unfortunately the market caught up on that as well, and LVMHs share price has doubled in just two years. And although the LVMH results justify a good performance of the share price, I do think LVMH is getting a little pricey.

  • [By ]

    French luxury house LVMH SE (LVMUY) stock surged 3.55% in Paris, changing hands at 278.8 after it reported better-than-expected first quarter sales. Organic revenues rose by 13% in the first three months of the year, driven by its fashion and leather goods division.

  • [By Shane Hupp]

    LVMH Moet Hennessy Louis Vuitton (OTCMKTS:LVMUY) was upgraded by ValuEngine from a “hold” rating to a “buy” rating in a research report issued on Saturday.

  • [By Leo Sun]

    At $126, Tiffany trades at about 27 times this year’s earnings estimate — which is a premium valuation relative to the midpoint of its forecast for 12% growth. LVMH (NASDAQOTH:LVMUY), which owns Tiffany’s rival(and Bogliolo’s former employer) Bulgari, trades at just 25 times this year’s earnings — and analysts expect its EPS to jump 16%. Bulgari, like Tiffany, is pivoting away fromits “old world” charms toward edgier marketing campaigns that target younger shoppers.

Hot Medical Stocks To Watch Right Now: Insulet Corporation(PODD)

Advisors’ Opinion:

  • [By Chris Lange]

    Insulet Corp. (NASDAQ: PODD) released its most recent earnings report after the markets closed on Wednesday. The company posted a net loss of $0.12 per share on $130.5 million in revenue, versus consensus estimates that called for a net loss of $0.08 per share on $125.3 million in revenue. Analysts weighed in on the firm:

  • [By Chris Neiger, Anders Bylund, and Todd Campbell]

    The great news is that there are plenty of companies that have not only doubled their share price over the years, but are also solid long-term investments. We reached out to three Motley Fool investors to find companies that fit that description. They came back withSolarEdge (NASDAQ:SEDG),Insulet(NASDAQ:PODD), and NVIDIA(NASDAQ:NVDA). Read on to find out why.

  • [By Stephan Byrd]

    Insulet Co. (NASDAQ:PODD) hit a new 52-week high and low on Friday after the company announced better than expected quarterly earnings. The company traded as low as $94.25 and last traded at $83.83, with a volume of 788324 shares trading hands. The stock had previously closed at $87.09.

  • [By Todd Campbell]

    It’s not just drugmakers that are disrupting the massive diabetes market. Medical device makers are also developing new approaches that can help diabetics better control their disease. From medtech Goliaths Medtronic (NYSE:MDT) and Abbott Labs (NYSE:ABT) to small pure plays Dexcom (NASDAQ:DXCM), Insulet Corp.(NASDAQ:PODD), and Tandem Diabetes Care (NASDAQ:TNDM), we’ve got you covered.

  • [By Todd Campbell]

    Systems fromInsulet (NASDAQ:PODD) and Tandem Diabetes Care (NASDAQ:TNDM)are among those closest to competing against Medtronic.InInsulet’s case, it’s pairing up its popular OmniPod, a device that can be attached to the skin to deliver insulin for up to three days, with Dexcom’s (NASDAQ:DXCM) popular G5 CGM, which charts blood glucose levels over time to provide greater insight.Tandem’scombining its t:slim insulin pump with Dexcom’s G5 CGM, too.

Hot Medical Stocks To Watch Right Now: Tandem Diabetes Care, Inc.(TNDM)

Advisors’ Opinion:

  • [By Todd Campbell]

    Medtronic is the only maker of an artificial pancreas right now, butother companies are developing their own closed-loop systems, and will launch them soon. Those closest to debuting them are the privately held Bigfoot Biomedical,Insulet (NASDAQ:PODD), and Tandem Diabetes Care (NASDAQ:TNDM). Bigfoot Biomedical isusing Abbott’s Freestyle Libre, while Insulet and Tandem Diabetes are using DexCom’s CGMs.

  • [By Logan Wallace]

    Tandem Diabetes Care (NASDAQ:TNDM)’s share price gapped up before the market opened on Tuesday . The stock had previously closed at $12.00, but opened at $10.78. Tandem Diabetes Care shares last traded at $11.27, with a volume of 227204 shares.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    World Fuel Services Corporation (NYSE: INT) tumbled 18 percent to $22.90 following Q1 results.
    Biglari Holdings Inc. (NYSE: BH) fell 17.4 percent to $349.52. Washington Prime Group will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1.
    Flex Ltd. (NASDAQ: FLEX) dipped 15.7 percent to $14.03 after a mixed fourth quarter report.
    FormFactor, Inc. (NASDAQ: FORM) fell 15.3 percent to $11.65. FormFactor is expected to release Q1 results on May 2.
    Data I/O Corporation (NASDAQ: DAIO) dropped 14.3 percent to $6.24 following Q1 results.
    National Instruments Corporation (NASDAQ: NATI) fell 14.3 percent to $ 42.34 after reporting Q1 results.
    United States Steel Corporation (NYSE: X) dipped 14.2 percent to $32.37 following Q1 results.
    Civeo Corporation (NYSE: CVEO) dropped 13.5 percent to $3.33. Civeo posted a Q1 loss of $0.42 per share on sales of $101.504 million.
    athenahealth, Inc. (NASDAQ: ATHN) fell 12.4 percent to $125.310 after reporting Q1 results.
    Charter Communications, Inc. (NASDAQ: CHTR) shares tumbled 12.1 percent to $262.06 as the company posted Q1 results.
    Value Line, Inc. (NASDAQ: VALU) fell 11.3 percent to $19.10.
    Federated Investors, Inc. (NYSE: FII) shares dropped 11.2 percent to $27.605 after the company posted downbeat quarterly earnings.
    AV Homes, Inc. (NASDAQ: AVHI) declined 10.7 percent to $17.20 following Q1 results.
    CalAmp Corp. (NASDAQ: CAMP) dropped 9.4 percent to $21.01 after reporting Q4 results.
    Tandem Diabetes Care, Inc. (NASDAQ: TNDM) shares fell 8.9 percent to $7.280 following mixed Q1 results.
    Sony Corporation (NYSE: SNE) shares fell 8.4 percent to $45.97 after reporting Q4 results.
    LogMeIn Inc (NASDAQ: LOGM) fell 8.2 percent to $109.825. LogMeIn reported upbeat earnings for its first quarter, but issued weak second quarter and FY18 earning guidance.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO

  • [By Motley Fool Staff]

    DexCom Inc. (NASDAQ:DXCM), Insulet (NASDAQ:PODD), and Tandem Diabetes (NASDAQ:TNDM) are working on new medical devices that could significantly improve the lives of people with diabetes. Addressing this massive market is a big opportunity, but are these stocks worth adding to your portfolio?

Hot Stocks To Watch Right Now

What happened

Shares of the embattled drugmaker Valeant Pharmaceuticals International (NYSE:VRX) rose by as much as 17.1% today on extremely heavy volume. The catalyst?

Valeant’s shares are responding positively to three material events:

The company reported stronger-than-expected sales in the first quarter, beating consensus by a healthy $45 million. Based on the strength of its Bausch & Lomb and branded drug segments, Valeant also revised its annual revenue guidance for the year to between $8.15 billion and $8.35 billion. The company’s previous guidance called for annual sales to range from $8.10 billion to $8.30 billion. Lastly, Valeant announced that it will change its name this coming July to Bausch Health Companies Inc. in order to move past the misdeeds of the company’s former management team.

Image source: Getty Images.

Hot Stocks To Watch Right Now: Insulet Corporation(PODD)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Insulet Co. (NASDAQ:PODD) hit a new 52-week high and low on Friday after the company announced better than expected quarterly earnings. The company traded as low as $94.25 and last traded at $83.83, with a volume of 788324 shares trading hands. The stock had previously closed at $87.09.

  • [By Todd Campbell]

    Systems fromInsulet (NASDAQ:PODD) and Tandem Diabetes Care (NASDAQ:TNDM)are among those closest to competing against Medtronic.InInsulet’s case, it’s pairing up its popular OmniPod, a device that can be attached to the skin to deliver insulin for up to three days, with Dexcom’s (NASDAQ:DXCM) popular G5 CGM, which charts blood glucose levels over time to provide greater insight.Tandem’scombining its t:slim insulin pump with Dexcom’s G5 CGM, too.

  • [By Stephan Byrd]

    Rockefeller Capital Management L.P. purchased a new stake in Insulet Co. (NASDAQ:PODD) during the first quarter, HoldingsChannel reports. The firm purchased 438,473 shares of the medical instruments supplier’s stock, valued at approximately $38,007,000.

Hot Stocks To Watch Right Now: LG Display Co., Ltd.(LPL)

Advisors’ Opinion:

  • [By Evan Niu, CFA]

    Apple has been working to bring LG Display (NYSE:LPL) onboard as a second supplier, but the latter company has been hitting roadblocks in terms of manufacturing capacity and quality requirements. However, it sounds like LG is making progress.

  • [By Ashraf Eassa]

    LG Display (NYSE: LPL) has been long been rumored to be vying aggressively for Apple’s OLED display business, so it wouldn’t be surprising to see the company benefit from Apple’s shift from LCDs to OLED-based displays. LG Display could end up supplying OLED panels to Apple for this year’s iPhones, but there have been reports that LG Display is struggling to meet Apple’s stringent quality standards. There have also been rumors that Chinese display maker BOE is also vying to supply Apple with OLED displays.

  • [By Shane Hupp]

    ValuEngine downgraded shares of LG Display (NYSE:LPL) from a sell rating to a strong sell rating in a research note issued to investors on Tuesday.

  • [By Steve Symington]

    The same sources noted that if Apple ultimately opts to launch more than three iPhone models in 2019, it may be forced to continue using LCD displays in at least one model because of manufacturing bottlenecks. But assuming Apple moves forward with its OLED-centric plans, it’s likely it will continue sourcing OLED panels from Samsung Display — which currently serves as Apple’s sole OLED display provider — while enlisting LG Display (NYSE:LPL) as a secondary supplier.

Hot Stocks To Watch Right Now: Federal Agricultural Mortgage Corporation(AGM)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Acacia Communications, Inc. (NASDAQ: ACIA) shares rose 18.3 percent to $37.25 in pre-market trading after gaining 1.74 percent on Friday.
    Kitov Pharma Ltd (NASDAQ: KTOV) rose 12.1 percent to $2.69 in pre-market trading after surging 4.80 percent on Friday.
    NXP Semiconductors N.V. (NASDAQ: NXPI) rose 10.9 percent to $109.75 in pre-market trading after Bloomberg reported that the China’s Commerce Ministry has restarted its review of QUALCOMM Incorporated’s (NASDAQ: QCOM) proposed takeover of NXP Semiconductors.
    Renewable Energy Group, Inc. (NASDAQ: REGI) rose 10.6 percent to $15.20 in pre-market trading. Renewable Energy will replace Synchronoss Technologies Inc. (NASDAQ: SNCR) in the S&P SmallCap 600 on Tuesday, May 15.
    NeoPhotonics Corporation (NYSE: NPTN) rose 10 percent to $6.40 in pre-market trading.
    Vaxart, Inc. (NASDAQ: VXRT) shares rose 8 percent to $5.54 in pre-market trading after gaining 2.19 percent on Friday.
    Profire Energy, Inc. (NASDAQ: PFIE) rose 7.3 percent to $4.58 in pre-market trading after gaining 6.22 percent on Friday.
    Marvell Technology Group Ltd. (NASDAQ: MRVL) rose 7 percent to $22.49 in pre-market trading after falling 1.96 percent on Friday.
    Oclaro, Inc. (NASDAQ: OCLR) shares rose 6.9 percent to $9.16 in pre-market trading.
    TransEnterix, Inc. (NYSE: TRXC) rose 5.7 percent to $2.24 in pre-market trading after gaining 3.92 percent on Friday.
    CVR Refining, LP (NYSE: CVRR) rose 5.4 percent to $19.70 in pre-market trading.
    Federal Agricultural Mortgage Corporation (NYSE: AGM) rose 5.2 percent to $92.95 in pre-market trading.
    International Game Technology PLC (NYSE: IGT) rose 5.2 percent to $29.94 in pre-market trading.
    Lumentum Holdings Inc. (NASDAQ: LITE) shares rose 5.1 percent to $66.30 in the pre-market trading session.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5 percent to $10.70 in pre-market trading after climbing 15.66 percent on Friday.
    Finisar
  • [By Stephan Byrd]

    Here are some of the headlines that may have impacted Accern’s rankings:

    Get Federal Agricultural Mortgage alerts:

    Zacks: Federal Agricultural Mortgage Co. (AGM) Given Average Rating of “Strong Buy” by Analysts (americanbankingnews.com) Federal Agricultural Mortgage Co. (AGM) Announces $0.58 Quarterly Dividend (americanbankingnews.com) Federal Agricultural Mortgage Corporation: Farmer Mac Declares Dividends and Announces Conference Call for First Quarter 2018 Results (twst.com) Federal Agricultural Mortgage (AGM) Set to Announce Earnings on Tuesday (americanbankingnews.com)

    Federal Agricultural Mortgage stock opened at $87.14 on Monday. The company has a market capitalization of $925.08, a PE ratio of 14.17 and a beta of 1.18. Federal Agricultural Mortgage has a twelve month low of $54.51 and a twelve month high of $92.57. The company has a quick ratio of 0.37, a current ratio of 0.37 and a debt-to-equity ratio of 2.87.

Hot Stocks To Watch Right Now: WPX Energy, Inc.(WPX)

Advisors’ Opinion:

  • [By Joseph Griffin]

    WPX Energy (NYSE:WPX) had its price target lifted by Stifel Nicolaus from $27.00 to $28.00 in a research note issued to investors on Wednesday. They currently have a buy rating on the oil and gas producer’s stock.

  • [By Shane Hupp]

    US Capital Advisors initiated coverage on shares of WPX Energy (NYSE:WPX) in a research note issued to investors on Monday. The firm issued a buy rating on the oil and gas producer’s stock.

  • [By Shane Hupp]

    Hodges Capital Management Inc. lowered its stake in shares of WPX Energy (NYSE:WPX) by 1.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,047,818 shares of the oil and gas producer’s stock after selling 17,025 shares during the period. WPX Energy accounts for about 1.2% of Hodges Capital Management Inc.’s investment portfolio, making the stock its 23rd largest position. Hodges Capital Management Inc. owned about 0.26% of WPX Energy worth $15,487,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Hot Stocks To Watch Right Now: Univest Corporation of Pennsylvania(UVSP)

Advisors’ Opinion:

  • [By Ethan Ryder]

    The Manufacturers Life Insurance Company raised its position in shares of Univest Co. of Pennsylvania (NASDAQ:UVSP) by 65.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 353,718 shares of the financial services provider’s stock after buying an additional 139,590 shares during the period. The Manufacturers Life Insurance Company’s holdings in Univest Co. of Pennsylvania were worth $9,799,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Stephan Byrd]

    Univest Co. of Pennsylvania (NASDAQ:UVSP) was upgraded by BidaskClub from a “sell” rating to a “hold” rating in a report issued on Wednesday.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Univest Co. of Pennsylvania (UVSP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

foreign investment

Peter Krauth

Gold is on track for a 2.4% loss this week, but our long-term gold price forecast sees prices rising 14% this year.

Gold prices have been resilient in the face of bearish market forces this week, and I see that resilience continuing this year.

You’d think the Dow Jones hitting 21,000 would be enough to drag the price of gold back below the $1,200 level. If not, then maybe a rallying U.S. dollar might have done so.

But that hasn’t been the case, as gold prices have been holding up well in the face of these factors.

The surging stock market comes on the heels of Trump’s promised tax cuts to boost the economy. The Fed’s talking up the odds of a March rate hike, and that’s reflected in a stronger dollar. And the long-term gold price has remained strong, up 8.4% since the Fed’s last rate hike on Dec. 14.

Don’t Miss: Our Complimentary Guide to Gold Investing in 2017

foreign investment: Public Service Enterprise Group Incorporated(PEG)

Advisors’ Opinion:

  • [By Stephan Byrd]

    FDx Advisors Inc. lowered its stake in shares of Public Service Co. (NYSE:PEG) by 15.8% during the 1st quarter, HoldingsChannel.com reports. The firm owned 36,891 shares of the utilities provider’s stock after selling 6,935 shares during the quarter. FDx Advisors Inc.’s holdings in Public Service were worth $1,853,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Media headlines about Public Service (NYSE:PEG) have trended somewhat positive recently, according to Accern. The research firm identifies negative and positive press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Public Service earned a media sentiment score of 0.04 on Accern’s scale. Accern also gave headlines about the utilities provider an impact score of 46.5923185859882 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

foreign investment: Diebold, Incorporated(DBD)

Advisors’ Opinion:

  • [By Paul Ausick]

    Diebold Nixdorf Inc. (NYSE: DBD) fell by about 5.1% Friday to post a new 52-week low of $11.43 after closing at $12.05 on Thursday. The 52-week high is $28.80. Volume of about 4.4 million was about three times the daily average of about 1.4 million. The company had no specific news.

  • [By Ethan Ryder]

    Here are some of the media headlines that may have impacted Accern Sentiment Analysis’s analysis:

    VeriFone (PAY) and Diebold Nixdorf (DBD) Financial Survey (americanbankingnews.com) NCR (NCR) versus Diebold Nixdorf (DBD) Critical Survey (americanbankingnews.com) Diebold Nixdorf, Incorporated (DBD) stock represents -49.50% move from 52-week high (analystrecommendation.com) Self-checkout System Market 2018 Key Players Diebold Nixdorf, ECR Software (ECRS) Corp., Pan-Oston Co, NCR … (theanalystfinancial.com) Diebold Nixdorf (DBD) Downgraded to “Neutral” at JPMorgan Chase (americanbankingnews.com)

    Shares of Diebold Nixdorf stock opened at $14.80 on Monday. The company has a current ratio of 1.39, a quick ratio of 0.98 and a debt-to-equity ratio of 3.53. Diebold Nixdorf has a 52 week low of $12.90 and a 52 week high of $29.80. The stock has a market capitalization of $1,123.92, a price-to-earnings ratio of 13.10, a price-to-earnings-growth ratio of 4.24 and a beta of 2.05.

foreign investment: Sohu.com Inc.(SOHU)

Advisors’ Opinion:

  • [By Rick Munarriz]

    The market isn’t warming up toSohu.com’s(NASDAQ:SOHU)latest financial report. Its shares are hitting their lowest levels since the summer of 2007 after the Chinese online advertising, search, and gaming specialist posted disappointing first-quarter results on Wednesday morning.

  • [By Daniel Sparks]

    Shares of Chinese internet company Sohu.com (NASDAQ:SOHU) fell as much as 11.8% on Wednesday, following the company’s first-quarter earnings release. The stock is down 8.4% at the time of this writing.

  • [By Rick Munarriz]

    I’ve been coveringSohu.com (NASDAQ:SOHU)for awhile, so when the Chinese internet pioneer announced plans tospin off Sogou, I was more than a little interested. Sogou has been the main growth driver at Sohu for years. With Sohu’s online advertising business meandering and its internet gaming business proving volatile, search has been its crown jewel.

foreign investment: Merck & Company, Inc.(MRK)

Advisors’ Opinion:

  • [By Chris Lange]

    And Merck & Co. Inc. (NYSE: MRK) is set to report its fourth-quarter results on Friday. The consensus estimates are EPS of $0.94 and $10.5 billion in revenue. The share price was last seen at $62.04. The consensus price target is $66.86, and the 52-week range is $53.63 to $66.80.

  • [By Paul Ausick]

    The Dow stock posting the largest daily percentage gain ahead of the close Wednesday was Merck & Co. Inc. (NYSE: MRK) which traded up about 2.55% at $55.12. The stock’s 52-week range is $52.97 to $66.41. Volume was about 30% below the daily average of around 13 million. The company had no specific news.

  • [By Chris Lange]

    Shares of Merck & Co. Inc. (NYSE: MRK) had a boost early Monday after the firm announced that its Phase 3 trial of Keytruda for the treatment of metastatic non-small cell lung cancer (NSCLC) met its primary endpoint for overall survival.

  • [By Chris Lange]

    The number of Merck & Co. Inc. (NYSE: MRK) shares short decreased to 22.95 million from 23.67 million in the previous period. Its shares were trading at $60.09, in a 52-week range of $52.83 to $66.41.

  • [By Cory Renauer]

    A failure in the first of a long slate of pivotal trials puts the future of thisMerck & Co. (NYSE:MRK) partnered program on shaky ground. Luckily, the once-failed candidate isn’t the only iron Incyte has in the fire. Here’s a look at why this stock is a lot more attractive now than you might think.

  • [By Jon C. Ogg]

    Merck & Co. Inc. (NYSE: MRK) was raised to Buy from Neutral at Goldman Sachs. The shares closed up 0.3% at $58.83 on Friday but were indicated up 2.2% at $60.15. Merck has a consensus target price of $66.55.

foreign investment: Insulet Corporation(PODD)

Advisors’ Opinion:

  • [By Shane Hupp]

    Insulet Co. (NASDAQ:PODD) – Stock analysts at Oppenheimer decreased their Q4 2018 earnings estimates for shares of Insulet in a research report issued to clients and investors on Friday, May 4th. Oppenheimer analyst S. Lichtman now forecasts that the medical instruments supplier will post earnings of $0.01 per share for the quarter, down from their prior estimate of $0.05. Oppenheimer has a “Hold” rating and a $90.00 price objective on the stock. Oppenheimer also issued estimates for Insulet’s FY2019 earnings at $0.35 EPS.

  • [By Chris Lange]

    Insulet Corp. (NASDAQ: PODD) released its most recent earnings report after the markets closed on Wednesday. The company posted a net loss of $0.12 per share on $130.5 million in revenue, versus consensus estimates that called for a net loss of $0.08 per share on $125.3 million in revenue. Analysts weighed in on the firm:

  • [By Stephan Byrd]

    Insulet Co. (NASDAQ:PODD) hit a new 52-week high and low on Friday after the company announced better than expected quarterly earnings. The company traded as low as $94.25 and last traded at $83.83, with a volume of 788324 shares trading hands. The stock had previously closed at $87.09.

  • [By Beth McKenna]

    Insulet (NASDAQ:PODD)reported strong first-quarter 2018 financial results after the market close on Thursday.

    The drug delivery company, which is a leader in tubeless insulin pump technology with its Omnipod Insulin Management System,delivered revenue growth of 21% year over year — exceeding its guidance — and narrowed its loss per share to $0.11 from $0.17 in the year-ago period.

foreign investment: Tallgrass Energy Partners, LP(TEP)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Tallgrass Energy Partners (TEP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    Cramer was bearish on Melco Resorts (MLCO) , Tallgrass Energy Partners (TEP) , Mallinckrodt (MNK) , Roku (ROKU) and Scotts Miracle-Gro (SMG) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By ]

    Tallgrass Energy Partners (TEP) : “That dividend is a red flag. That group has become a house of pain and I’m not going there.”

    Mallinckrodt (MNK) : “They had a better-than-expected quarter, but I am worried and I’m staying away.”

Top 10 Casino Stocks To Buy Right Now

Wynn Resorts, Limited (NASDAQ:WYNN) delivered strong results on Tuesday beating on the bottom line, but missing on the top. Personally, I love what I see at the top and bottom lines for WYNN stock.

The Macau nightmare appears to have come to an end, and it seems to me that the company is back on track. With Elaine Wynn also restructuring the board of directors, the goal appears to be wiping WYNN stock clean of any vestiges of her ex-husband’s sexual misconduct allegations.

Overall operating revenues for WYNN stock rose more than 20% to $1.72 billion. That came on the back of a 25% increase in casino revenues to $1.24 billion. Backing out the massive $464 million litigation settlement for the quarter, operating income came in at $382 million, up more than 50% from last year’s $250 million. Net income before income taxes came in at $225 million, up substantially from last year’s $135 million.

All in all, these numbers look pretty darn good to me. However, we want to drill down to make sure not missing anything.

Top 10 Casino Stocks To Buy Right Now: Brooks Automation Inc.(BRKS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Technology sector was the top gainer in the US market on Monday. Top gainers in the sector included Aviat Networks Inc (NASDAQ: AVNW), Cohu, Inc. (NASDAQ: COHU), and Brooks Automation, Inc (NASDAQ: BRKS).

  • [By Lisa Levin]

    In trading on Friday, technology shares fell 3.59 percent. Meanwhile, top losers in the sector included Ultra Clean Holdings Inc (NASDAQ: UCTT), down 5 percent, and Brooks Automation, Inc (NASDAQ: BRKS), down 10 percent.

Top 10 Casino Stocks To Buy Right Now: Crystal Rock Holdings, Inc.(CRVP)

Advisors’ Opinion:

  • [By Peter Graham]

    Meanwhile, small capCrystal Rock Holdings (NYSEAMEX: CRVP) is the largest independent home and office distributor of its kind in the United States -marketing water, coffee and other home and office refreshment products throughout the Northeast through its subsidiary Crystal Rock LLC.The Companybottles and distributes natural spring water under the Vermont Pure庐 brand, purified water with minerals added under the Crystal Rock庐 label andits own Cool Beans庐 coffee. The majority of sales are derived froman extensive route distribution system throughout the Northeast United States. Specifically, the Company sells major brands in three and five gallon bottles to homes and offices throughout New England, New York, and New Jersey. In addition, Crystal Rock庐 is distributed in southern New England and upstate and western New York while Vermont Pure is primarily distributed throughout northern New England and upstate New York and secondarily in southern New England.

Top 10 Casino Stocks To Buy Right Now: Cooper Tire & Rubber Company(CTB)

Advisors’ Opinion:

  • [By Matt Hogan]

    Finbox.io fair value data (as of January 4) shows that there are only five US manufacturing stocks that have 25% or more margin of safety: Vera Bradley, Inc. (NASDAQ: VRA), Cooper Tire & Rubber Co (NYSE: CTB), Farmer Brothers Co. (NASDAQ: FARM), Allergan plc Ordinary Shares (NYSE: AGN) and Motorcar Parts of America, Inc. (NASDAQ: MPAA).

Top 10 Casino Stocks To Buy Right Now: U S Concrete, Inc.(USCR)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Coming up in tonight’s episode of Mad Money: Cramer interviews Bill Sandbrook, CEO of U.S. Concrete (USCR)  and focuses on opportunities for Xilinx (XLNX) .  Plus, don’t miss the Lightning Round. Which stocks is Cramer bullish on?

  • [By Lisa Levin]

    In trading on Friday, basic materials shares fell 0.73 percent. Meanwhile, top losers in the sector included US Concrete Inc (NASDAQ: USCR), down 8 percent, and Seabridge Gold, Inc. (USA) (NYSE: SA), down 5 percent.

  • [By Lisa Levin]

    In trading on Friday, basic materials shares fell 0.36 percent. Meanwhile, top losers in the sector included US Concrete Inc (NASDAQ: USCR), down 10 percent, and Commercial Metals Company (NYSE: CMC), down 4 percent.

Top 10 Casino Stocks To Buy Right Now: Caesars Acquisition Company(CACQ)

Advisors’ Opinion:

  • [By Travis Hoium]

    The big unknown with Caesars Entertainment is how the company’s proposed acquisition of Caesars Acquisition Company (NASDAQ:CACQ) and the resolution of Caesars Entertainment Operating Company’s bankruptcy will end up.

Top 10 Casino Stocks To Buy Right Now: Insulet Corporation(PODD)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows MannKind Corporation peaking in 2014 before falling below the more steady performance of diabetes or insulin stocks like large cap Novo Nordisk A/S (NYSE: NVO) and small cap Insulet Corporation (NASDAQ: PODD):

  • [By Brian Feroldi]

    Shares of Insulet Corporation(NASDAQ:PODD), a medical device company primarily focused on diabetes,rose by as much as 11% in afternoon trading on Friday.

  • [By Chris Lange]

    Insulet Corp. (NASDAQ: PODD) released its most recent earnings report after the markets closed on Wednesday. The company posted a net loss of $0.12 per share on $130.5 million in revenue, versus consensus estimates that called for a net loss of $0.08 per share on $125.3 million in revenue. Analysts weighed in on the firm:

  • [By Peter Graham]

    A long term performance chart shows MannKind Corporation having once been a highflyerwhile the performance of large cap insulin and diabetes stockNovo Nordisk A/S (NYSE: NVO) has fallen off and small cap Insulet Corporation (NASDAQ: PODD) has actually performed better:

Top 10 Casino Stocks To Buy Right Now: Shake Shack, Inc.(SHAK)

Advisors’ Opinion:

  • [By Spencer Israel]

    The following are some of the stocks discussed on the show for which co-host Joel Elconin offered technical levels.

    Bank of America Corp (NYSE: BAC) hit a low last week of $22.43, and has a big psychological level of $22.
    Goldman Sachs Group Inc (NYSE: GS) has two minor support levels from early December of $221.22 and $220.35. Under $220 it gets dicey, with support at $214.97 and $209.92.
    United States Steel Corporation (NYSE: X) has a key low of $31.33 from February 2. That number serves as support.
    Best Buy Co Inc (NYSE: BBY) has a triple top at $45.15. It's currently in a trading range from $43.75-$45.70.
    Shake Shack Inc (NYSE: SHAK) has been range bound over the last four days from $31.68 to $32.62. It has major support at the all-time low from March 15 at $30.36.
    Warren Lorenz, CEO of TechMeetsTrader, joined the show to discuss his "Facebook for stocks" platform, and how he learned how to trade by watching trading communities. Listen to the full interview with Lorenz here.
    Tommy Lackey, managing partner and portfolio manager at Relativity Capital Advisors, told us which stocks are on his nitrous scans and meltdown filters this morning. Those include XOMA Corporation (NASDAQ: XOMA) Whirlpool Corporation (NYSE: WHR) and Bed Bath & Beyond Inc. (NASDAQ: BBBY). Listen to the full interview with Lackey here.
    With the market in a slight selloff following Friday's healthcare fallout, the focus today will be which sectors, if any, rebound throughout the day. With steel stocks looking weak and gold minors and utilities looking strong, co-host Dennis Dick said he'll try to jump into those sectors if they stay weak after the open. Hear what other sectors Dick is watching here.
    With Snap Inc (NYSE: SNAP)'s 25-day quiet period for analysts over, the Street was treated to bullish ratings by Goldman Sachs, Citigroup, Morgan Stanley and others. It's worth noting, however, most of Monday morning

  • [By WWW.GURUFOCUS.COM]

    It wasn’t too long ago that Shake Shack (NYSE:SHAK) was a darling growth stock. After its initial public offering at $45 per share in early 2015, shares of the high-growth fast food restaurant soared as high as $92 by late May of that year.

  • [By Peter Graham]

    A long term performance chart shows Sonic Corporation outperforming burger stock peers Red Robin Gourmet Burgers, Inc (NASDAQ: RRGB),Habit Restaurants Inc (NASDAQ: HABT) andShake Shack Inc (NYSE: SHAK):

  • [By Peter Graham]

    Small cap New York City based burger stock Shake Shack Inc (NYSE: SHAK) reportedQ2 2017 earnings after the market closed Thursday. Before earnings were reported, Barrons noted thatthere were twice as many rainy days in the Northeast (where most of Shake Shacks locations are) as there were a year ago and more than half of the burger chains restaurants in New York have outdoor seating.

  • [By Jeremy Bowman]

    No two companies may better represent the opposing poles of the fast-food industry thanMcDonald’s Corporation(NYSE:MCD) and Shake Shack Inc.(NYSE:SHAK). McDonald’s is the biggest fast-food company in the world by sales and market value, and the Golden Arches represent the quintessential burger chain in much of the world. Shake Shack, on the other hand, is one of the companies defining the better-burger space, and its founder, Danny Meyer, likes to call the brand “fine casual.” Shake Shack charges more for its burgers than McDonald’s, but offers better-quality food.

  • [By Chris Lange]

    Shake Shack Inc. (NYSE: SHAK) reported fourth quarter financial results after markets closed on Wednesday. The burger joint said that it had $0.09 in earnings per share (EPS) and $73.3 million in revenue. The same period from last year had $0.08 in EPS and $51.06 million in revenue. Thomson Reuters forecast $0.09 in EPS and $70.68 million in revenue.

Top 10 Casino Stocks To Buy Right Now: VIVUS, Inc.(VVUS)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term chart shows Arena Pharmaceuticals along with its small capobesitytreatmentpeers EnteroMedics Inc (NASDAQ: ETRM), Orexigen Therapeutics, Inc (NASDAQ: OREX) and VIVUS, Inc (NASDAQ: VVUS) all causing severe weight loss for investor portfolios:

  • [By Keith Speights]

    Arena is out of the obesity drug business, but what about Orexigen Therapeutics (NASDAQ:OREX) or VIVUS (NASDAQ:VVUS)? The problem is that they’re both too dependent on their respective obesity drugs, Contrave and Qsymia. Neither of the drugs have performed up to expectations.

Top 10 Casino Stocks To Buy Right Now: Lowe’s Companies Inc.(LOW)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart for Lumber Liquidators Holdings sort of stabilizing over the past two years while large capsThe Home Depot, Inc (NYSE: HD)and Lowe’s Companies, Inc (NYSE: LOW) have been more steady performers:

  • [By WWW.THESTREET.COM]

    Williams-Sonoma (WSM) reported a mixed third quarter. Comparable-brand sales at Pottery Barn fell, while sales at West Elm continued to outpace its other brands. Home Depot (HD) lifted its full-year earnings estimates after strong sales growth in its third quarter. Lowe’s (LOW) fell short of third-quarter earnings and revenue estimates, while same-store sales growth of 2.7% missed analysts’ 3% target.

  • [By Teresa Rivas]

    Lowes(LOW) soared on Wednesday after reporting fourth-quarter earnings, making it the best performer in the S&P 500.

    Getty Images

    Today the shares are lower, but RBC Capital Markets’Scot Ciccarelli writes that the quarter’s strength supports more gains ahead.

    Ciccarelli and his team reiterated an Outperform rating on the stock and raised their price target $7, to $90, writing that the sales trends are positive and the macro backdrop, including a robust housing and construction sector, remains supportive for Lowe’s. They still preferHome Depot(HD), saying it provides more consistent execution, but are upbeat about Lowe’s ability to keep climbing.

    Details from their note about Lowe’s upbeat same-store sales:

    Lowes monthly comps were very healthy, up 4.7%, 6.3% and 4.2% (Nov-Jan), compared to Home Depots 6.0%, 8.0%, 5.1%. Both comp ticket (+4%) and transaction growth (+1.1%) contributed to the comp after stalling in recent quarters (2Q and 3Q traffic growth were sub-1%). Further, 2-year transaction comps (which we view as the run-rate) improved to ~4.7% in 4Q from 3Qs 3.0% and 2Qs 1.3%. Comps in all regions and nearly all product categories were positive, and the Pro continued to comp above company average. Big-ticket was also strong (+9%), driven by categories such as Appliances, Kitchen and Lawn & Garden.

    Lowe’s is down down 0.9% to $80.70 in recent trading, although it’s up 13.5% since the start of the year.

  • [By Demitrios Kalogeropoulos]

    That’s why many investors shop among the short list ofDividend Aristocrats, which are companies that boast an unbroken streak of at least 25 years of consecutive payout raises. A few members of that elite group have fallen out of favor recently and could represent solid long-term buys. Below, we’ll look at the prospects for market-beating returns fromCoca-Cola(NYSE:KO),Target(NYSE:TGT), andLowe’s(NYSE:LOW).

Top 10 Casino Stocks To Buy Right Now: Estee Lauder Companies, Inc. (EL)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    GLP’s customers include Walmart (WMT) , Unilever (UL) , JD.com (JD) , Adidas (ADDYY) , Estee Lauder (EL) and L’Oreal (LRLCY) .

    The S$3.38 offer price represents 81% premium over its 12-month volume weighted average price and a 25% premium over its last full trading day before the announcement.

  • [By Ben Levisohn]

    The 20 stocks meeting those requirements are: Ralph Lauren (RL), Time Warner(TWX), Twenty-First Century Fox(FOXA), PepsiCo(PEP), Estee Lauder(EL), Tesoro(TSO), XL(XL), Ameriprise Financial,(AMP), Unum(UNM), Merck(MRK), AbbVie(ABBV), Gilead Sciences(GILD), General Dynamics(GD), Alaska Air(ALK), United Continental(UAL), Delta Air Lines(DAL), Oracle(ORCL), eBay(EBAY), Apple(AAPL), and Centurylink(CTL).

Best Blue Chip Stocks To Buy For 2018

On Tuesday, stocks closed mixed with a preference for small-caps as they took gains in some blue chips and big-cap stocks.

Profit-taking started immediately, with a divergence of better-quality stocks being sold. Banks and other financials fell 1.4% at the close, while technology gained 0.9% and consumer discretionary rose 0.5%. Eight of the eleven sectors of the 500 lost ground. From the election until Monday most investing was based on the expectations that the new administration will increase fiscal spending and lower corporate tax rates. The goal is to raise interest rates, inflation and promote growth.

Yesterday buying slowed slightly, but floor traders said that consolidations are a good sign and that the “reflation trade” will probably resume again. The chief investment officer at Wells Fargo Private Bank was quoted by The Wall Street Journal who said “there’s a level of optimism I haven’t seen in a while.”

Crude oil WTI fell 0.7% at $45.56 per barrel due to an EIA report that crude oil supplies increased by 5.27 million barrels instead of an estimate of 1.48 million.

Best Blue Chip Stocks To Buy For 2018: Sony Corp Ord(SNE)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    For those who want a general facsimile of the pay-TV bundle and access to the largest broadcast networks, there’s Sling TV from Dish Network (DISH) , DirecTV Now from   AT&T (T) and Sony’s (SNE) PlayStation Vue. In the coming weeks, they’ll be joined by Alphabet’s (GOOGL) YouTube TV and a still unnamed pay-TV service from Hulu, the video-on-demand service controlled jointly by Disney, Comcast’s (CMCSA) NBCUniversal and 21st Century Fox (FOXA) , along with Time Warner (TWX) holding a 10% stake.

  • [By Joe Tenebruso]

    15. To date, Sony (NYSE:SNE) has dominated the console wars, with sales of its PlayStation 4 recently surpassing 53 million units worldwide. That’s more than double the estimated 26 million Xbox One units Microsoft (NASDAQ:MSFT) has sold, and triple the 15 million Wii U units sold by Nintendo (NASDAQOTH:NTDOY), according to research companySuperData.

  • [By Leo Sun]

    By comparison, Sony (NYSE:SNE) was expected to sell about 2.6 million PlayStation VRs, and Samsung (NASDAQOTH:SSNLF) was expected to sell 2.3 million Gear VRs. Even Google’s new Daydream platform was projected to fuel sales of 450,000 compatible handsets. Those numbers clearly indicate that consumer demand for cheaper devices linked to smartphones or gaming consoles could continue outselling higher-end devices tethered to pricier PCs — which would be bad news for Oculus.

  • [By Jayson Derrick]

    One of Beneche’s top global picks is Sony Corp (ADR) (NYSE: SNE). The Japan-based company has “dramatically” changed over the past few years from operating divisions that deliver losses in mobile, PC and TV to now making profits in “great” franchises such as PlayStation and music with plenty of secular drivers ahead.

Best Blue Chip Stocks To Buy For 2018: Callon Petroleum Company(CPE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday’s regular session.

Best Blue Chip Stocks To Buy For 2018: Pharmerica Corporation(PMC)

Advisors’ Opinion:

  • [By Monica Gerson]

    PharMerica Corporation (NYSE: PMC) is estimated to report its quarterly earnings at $0.43 per share on revenue of $509.45 million.

    United States Cellular Corp (NYSE: USM) is projected to report its quarterly earnings at $0.26 per share on revenue of $975.54 million.

Best Blue Chip Stocks To Buy For 2018: ARMOUR Residential REIT, Inc.(ARR)

Advisors’ Opinion:

  • [By Amanda Alix]

    It was just about one year ago that QE3 made its debut, and mortgage REITs, particularly agency-only players like Annaly Capital (NYSE: NLY  ) , Armour Residential (NYSE: ARR  ) , and American Capital Agency (NASDAQ: AGNC  ) began moaning about the increased competition for mortgage-backed securities guaranteed by Fannie Mae and Freddie Mac.

  • [By Lee Jackson]

    These companies also reported insider buying last week: Armour Residential REIT Inc. (NYSE: ARR), Ducommun Inc. (NYSE: DCO), PJT Partners Inc. (NYSE; PJT), Sonic Automotive Inc. (NYSE: SAH)and Tandy Leather Factory Inc. (NASDAQ: TLF).

  • [By Amanda Alix]

    This development will likely give battered mREITs like Annaly Capital (NYSE: NLY  ) , Armour Residential (NYSE: ARR  ) , and American Capital Agency (NASDAQ: AGNC  ) a huge boost as investors begin to feel less panic regarding a tapering of the current QE3 program. Markets have responded to the Summers announcement by soaring skyward, apparently feeling relief and confidence about the fate of the taper.

Best Blue Chip Stocks To Buy For 2018: Insulet Corporation(PODD)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows MannKind Corporation peaking in 2014 before falling below the more steady performance of diabetes or insulin stocks like large cap Novo Nordisk A/S (NYSE: NVO) and small cap Insulet Corporation (NASDAQ: PODD):

  • [By Chris Lange]

    Insulet Corp. (NASDAQ: PODD) released its most recent earnings report after the markets closed on Wednesday. The company posted a net loss of $0.12 per share on $130.5 million in revenue, versus consensus estimates that called for a net loss of $0.08 per share on $125.3 million in revenue. Analysts weighed in on the firm:

  • [By Brian Feroldi]

    Shares of Insulet Corporation(NASDAQ:PODD), a medical device company primarily focused on diabetes,rose by as much as 11% in afternoon trading on Friday.

  • [By Peter Graham]

    A long term performance chart shows MannKind Corporation having once been a highflyerwhile the performance of large cap insulin and diabetes stockNovo Nordisk A/S (NYSE: NVO) has fallen off and small cap Insulet Corporation (NASDAQ: PODD) has actually performed better: